WT Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
WT Wealth Management's DGX Position: Q1 2021 in Review
WT Wealth Management sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 3,135 shares — an estimated $373K sold.
WT Wealth Management first reported a position in DGX in Q4 2020 and held it in 1 quarter. The position peaked at $373K in Q4 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.
- WT Wealth Management reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
- WT Wealth Management sold 3,135 Quest Diagnostics shares in Q1 2021, an estimated $373K.
- WT Wealth Management first reported a position in Quest Diagnostics in Q4 2020 and held it in 1 quarter.
- WT Wealth Management's Quest Diagnostics position peaked at $373K in Q4 2020.
- 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.
Based on WT Wealth Management's 13F filing for Q1 2021, filed 29 Apr 2021.